Terms: = Lymphoma AND TG, Thyroglobulin AND Treatment
138 results:
1. The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group.
Mallon B; Kaboré R; Couitchere L; Akonde FB; Narison MLR; Budiongo A; Dackono TA; Pondy A; Diedhiou F; Patte C; Steliarova-Foucher E; Clavel J
Pediatr Blood Cancer; 2023 Dec; 70(12):e30664. PubMed ID: 37732944
[TBL] [Abstract] [Full Text] [Related]
2.
Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
[TBL] [Abstract] [Full Text] [Related]
3. Granulomatous myopathy: Sarcoidosis and beyond.
Chompoopong P; Liewluck T
Muscle Nerve; 2023 Mar; 67(3):193-203. PubMed ID: 36352751
[TBL] [Abstract] [Full Text] [Related]
4. Gut-derived Endotoxin-TLR4 Signaling Drives MYC-Ig Translocation to Promote Lymphoproliferation through c-JUN and STAT3 Activation.
Rokan A; Hernandez JC; Nitiyanandan R; Lin ZY; Chen CL; Machida T; Li M; Khanuja J; Chen ML; Tahara SM; Siddiqi I; Machida K
Mol Cancer Res; 2023 Feb; 21(2):155-169. PubMed ID: 36287175
[TBL] [Abstract] [Full Text] [Related]
5. JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL.
Benyoucef A; Haigh K; Cuddihy A; Haigh JJ
Leukemia; 2022 Dec; 36(12):2802-2816. PubMed ID: 36229595
[TBL] [Abstract] [Full Text] [Related]
6. Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP.
Dong Q; Ou W; Wang M; Jiang T; Weng Y; Zhou X; Tang X
BMC Cancer; 2022 Sep; 22(1):988. PubMed ID: 36115970
[TBL] [Abstract] [Full Text] [Related]
7. A Retrospective Cohort Study of the Efficacy, Safety, and Clinical Value of 6-TG versus 6-MP Maintenance Therapy in Children with Acute Lymphoblastic Leukemia.
Tu M; Zhang A; Hu L; Wang F
Biomed Res Int; 2022; 2022():7580642. PubMed ID: 36046443
[TBL] [Abstract] [Full Text] [Related]
8. Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations.
Toksvang LN; Lee SHR; Yang JJ; Schmiegelow K
Leukemia; 2022 Jul; 36(7):1749-1758. PubMed ID: 35654820
[TBL] [Abstract] [Full Text] [Related]
9. Nano-curcumin supplementation in critically ill patients with sepsis: a randomized clinical trial investigating the inflammatory biomarkers, oxidative stress indices, endothelial function, clinical outcomes and nutritional status.
Karimi A; Naeini F; Niazkar HR; Tutunchi H; Musazadeh V; Mahmoodpoor A; Asghariazar V; Mobasseri M; Tarighat-Esfanjani A
Food Funct; 2022 Jun; 13(12):6596-6612. PubMed ID: 35621073
[TBL] [Abstract] [Full Text] [Related]
10. Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol.
Toksvang LN; Als-Nielsen B; Bacon C; Bertasiute R; Duarte X; Escherich G; Helgadottir EA; Johannsdottir IR; Jónsson ÓG; Kozlowski P; Langenskjöld C; Lepik K; Niinimäki R; Overgaard UM; Punab M; Räty R; Segers H; van der Sluis I; Smith OP; Strullu M; Vaitkevičienė G; Wik HS; Heyman M; Schmiegelow K
BMC Cancer; 2022 May; 22(1):483. PubMed ID: 35501736
[TBL] [Abstract] [Full Text] [Related]
11. Effects of imatinib on glycemic and lipid profiles: a retrospective cohort study.
Markovits N; Kurnik D; Friedrich C; Gueta I; Halkin H; David S; Lomnicky Y; Topol Y; Tirosh A; Loebstein R
Leuk Lymphoma; 2022 Sep; 63(9):2224-2232. PubMed ID: 35475716
[TBL] [Abstract] [Full Text] [Related]
12. Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid Leukemia Development.
Ma W; Liu Y; Lei P; Zhu M; Pan X
Curr Cancer Drug Targets; 2022; 22(5):404-413. PubMed ID: 35249489
[TBL] [Abstract] [Full Text] [Related]
13. Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model.
Xu Z; Lin S; Tong Z; Chen S; Cao Y; Li Q; Jiang Y; Cai W; Tong Y; Zahra BS; Wang P
J Ethnopharmacol; 2022 Mar; 285():114873. PubMed ID: 34848360
[TBL] [Abstract] [Full Text] [Related]
14. Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non-Hodgkin lymphoma.
Ribeiro ML; Reyes-Garau D; Vinyoles M; Profitós Pelejà N; Santos JC; Armengol M; Fernández-Serrano M; Sedó Mor A; Bech-Serra JJ; Blecua P; Musulen E; De La Torre C; Miskin H; Esteller M; Bosch F; Menéndez P; Normant E; Roué G
Clin Cancer Res; 2021 Dec; 27(23):6591-6601. PubMed ID: 34551904
[TBL] [Abstract] [Full Text] [Related]
15. High-fat diet alters stress behavior, inflammatory parameters and gut microbiota in Tg APP mice in a sex-specific manner.
Yanguas-Casás N; Torres C; Crespo-Castrillo A; Diaz-Pacheco S; Healy K; Stanton C; Chowen JA; Garcia-Segura LM; Arevalo MA; Cryan JF; de Ceballos ML
Neurobiol Dis; 2021 Nov; 159():105495. PubMed ID: 34478848
[TBL] [Abstract] [Full Text] [Related]
16. Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies.
Franca R; Braidotti S; Stocco G; Decorti G
Expert Opin Drug Metab Toxicol; 2021 Oct; 17(10):1187-1198. PubMed ID: 34452592
[TBL] [Abstract] [Full Text] [Related]
17. treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider.
El-Khoury H; Saifi O; Haddad S; Chahrour M; Ghanem KM; Mubarak Y; Tamim H; Makki M; Zakka C; Chan AK; Mahfouz R; Tarek N; El-Solh H; Abboud MR; Saab R; Muwakkit SA
Pediatr Blood Cancer; 2021 Nov; 68(11):e29210. PubMed ID: 34327817
[TBL] [Abstract] [Full Text] [Related]
18. Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
Toksvang LN; Andrés-Jensen L; Rank CU; Niinimäki R; Nersting J; Nielsen SN; Mogensen SS; Harila-Saari A; Abrahamsson J; Joelsson J; Overgaard UM; Quist-Paulsen P; Griškevičius L; Jónsson ÓG; Vaitkevičienė G; Frandsen TL; Toft N; Grell K; Schmiegelow K
Cancer Chemother Pharmacol; 2021 Nov; 88(5):911-917. PubMed ID: 34145469
[TBL] [Abstract] [Full Text] [Related]
19. Umbralisib: First Approval.
Dhillon S; Keam SJ
Drugs; 2021 May; 81(7):857-866. PubMed ID: 33797740
[TBL] [Abstract] [Full Text] [Related]
20. Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia.
Stanulla M; Schaeffeler E; Möricke A; Buchmann S; Zimmermann M; Igel S; Schmiegelow K; Flotho C; Hartmann H; Illsinger S; Sauerbrey A; Junk SV; Schütte P; Hinze L; Lauten M; Modlich S; Kolb R; Rossig C; Schwabe G; Gnekow AK; Fleischhack G; Schlegel PG; Schünemann HJ; Kratz CP; Cario G; Schrappe M; Schwab M
Leukemia; 2021 Sep; 35(9):2650-2657. PubMed ID: 33714975
[TBL] [Abstract] [Full Text] [Related]
[Next]
